Dayton Misfeldt
2018
In 2018, Dayton Misfeldt earned a total compensation of $574.9K as Interim CEO at Sunesis Pharmaceuticals.
Compensation breakdown
| Option Awards | $524,939 |
|---|---|
| Other | $50,000 |
| Total | $574,939 |
Misfeldt received $524.9K in option awards, accounting for 91% of the total pay in 2018.
Misfeldt also received $50K in other compensation.
Rankings
In 2018, Dayton Misfeldt's compensation ranked 11,427th out of 14,244 executives tracked by ExecPay. In other words, Misfeldt earned more than 19.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,427 out of 14,244 | 20th |
Division Manufacturing | 4,616 out of 5,759 | 20th |
Major group Chemicals And Allied Products | 1,749 out of 2,122 | 18th |
Industry group Drugs | 1,486 out of 1,811 | 18th |
Industry Pharmaceutical Preparations | 1,140 out of 1,385 | 18th |
Source: SEC filing on April 28, 2020.
Misfeldt's colleagues
We found one more compensation record of an executive who worked with Dayton Misfeldt at Sunesis Pharmaceuticals in 2018.
2018
William Quinn
Sunesis Pharmaceuticals